2024 Agenda

7:15 – 8:00 am PDT

EXPERIENCE

Octane Capital and Growth Breakfast (Invite Only)

WELCOME

Welcome and Introduction

Bill Carpou, CEO, Octane

Janelle Brunette, COO, Octane

KEYNOTE

Keynote introduced by Jim Mazzo, Executive Chairman, Neurotech; Co-Founder, Octane

Biodesign: Advancing The Healthtech Innovation Ecosystem For Better Patient Care

Josh Makower, MD, Professor of Medicine and of Bioengineering, Stanford University Schools of Medicine & Engineering;

Director & Co-Founder, Stanford Byers Center for Biodesign;

Chairman & Founder, ExploraMed Development, LLC

FIRESIDE CHAT

Scott Pantel, CEO, LSI and Bill Carpou, CEO, Octane

PANEL

The Impact of Emerging Technologies on Healthcare and MedTech

The healthcare and MedTech sectors are rapidly evolving due to the rise of technologies such as AI, robotics, 3D printing, wearables, and space-based drug development. These advancements are revolutionizing how care is delivered, improving diagnostics, and enabling more personalized treatments.

They will explore the profound impact of microgravity environments on drug development, the transformation of surgical practices through robotics and precision instruments, and the critical role of data analytics in enhancing operational efficiency and patient outcomes

Moderator: Jason Lee, K&L Gates 

Eric Gildenhuys, President and CEO, Rezultant Inc.

Mark Herbert, VP of Biopharma Business Development, Varda Space Industries

Jean-Pierre Hubschman, MD, Co-Founder & CEO, Horizon Surgical Systems

Ryan J. O’Connell, MD, Associate Chief Medical Information Officer, Clinical Informatics / Pathology, UC Irvine

Sumit Paliwal, Vice President, Diagnostics & Visualization, Surgical Instrumentation R&D, Alcon

Mark Silverman, Director, Omnichannel Strategy, AbbVie

EXPERIENCE

Morning Break

CAPITAL & GROWTH

Octane Portfolio Companies

Octane portfolio companies will pitch their products to our investor ecosystem with key strategics and physicians.

EXPERIENCE

LUNCH

PANEL

Regenerative Medicine: Bridging the Gap to Curative Therapies

Explore the innovations in regenerative medicine treatment. Discuss how regenerative technologies are accelerating drug discovery, optimizing cell therapies, and enhancing patient outcomes.

Moderator: Aileen J Anderson, PhD, Director, Sue and Bill Gross Stem Cell Research Center, UC Irvine

Christopher Duma, MD, FACS, President and Founder, Regeneration Biomedical, Inc.; Medical Director, Brain Tumor Program, and Chief of Service, Parkinson’s and Movement Disorder Programs, Hoag Hospital

Alex C. Minella, M.D., Medical Director, cGMP facility, Associate Clinical Professor (Hematology/Oncology), University of California, Irvine

Tanya Siddiqi, MD, Medical Director of Lymphoma, City of Hope Orange County

CAPITAL & GROWTH

Octane Portfolio Companies

Octane portfolio companies will pitch their products to our investor ecosystem with key strategics and physicians.

Emcee: Natalie Harney, Certified Business Performance Advisor, Insperity

Presenting Companies:
Autonomix 
Eisana
Automedicus
Magellan Biomedical
Sinaptica Therapeutics

Judges:
Len Brandt, CEO, D2M Venture Development
Randy Fisher, Direct, Private Capital Development, Insperity
Larry Stofko, OCG Executive in Residence, Octane; Venture Scout, Alumni Ventures

People’s Choice and Judge’s Choice Winners Voting & Announcement!

EXPERIENCE 

Afternoon Break

PANEL

Wearables for Monitoring and Managing Cancer Treatment Adverse Events

Advanced wearables with embedded sensors can track in real-time specific biomarkers and physiological indicators to provide insights into a patient’s physical and emotional state, allowing for earlier and timely interventions. They empower patients by giving them more control and understanding of their condition and how different activities, medications, or therapies affect their physical pain and mental health. Consistently monitoring symptoms allows patients to engage in more informed discussions with their healthcare providers. The result is personalized and effective treatment plans. Wearables tailored specifically for cancer patients could provide more targeted monitoring and management of cancer-related side effects.

Join Hoag’s panel of physician thought leaders and two early-stage, innovative companies to highlight examples of wearable monitoring and neuromodulation devices focused on measuring or treating chemo-induced pain and stress/anxiety in patients from cancer treatment side effects. The panel will address the role of these remote, non-invasive, digital health devices in appropriate management of cancer adverse events, and the overall improvement in patient health, wellness, holistic care experience, quality-of-life, as well as potential savings in healthcare costs.

Moderator: Michael Brant-Zawadzki, MD, FACR, Vice President, Clinical Research Administration, CATALiST (Center for Accelerating Technology and Life Sciences Translation), Addiction Services, Hoag Hospital

Charles J. De Mesa, DO, Chief of Interventional Pain, Physical Medicine & Rehabilitation for Hoag Spine Institute and Director of the Chronic Pain & Neuropathy Program in Hoag’s Pickup Family Neuroscience Institute

Kamran Ansari, CEO and Co-Founder, FluxWear – Advances in Wearable Neuromodulation to Reduce Chemotherapy’s Added Toll

Naama Mashiach, CEO and Co-Founder, Buzzy Platform – Mind, Body, and AI: The Future of Personalized Healthcare

FIRESIDE CHAT

Highlighting Innovations in Neuroscience and the Annual Brain Health Summit

Bill Carpou, CEO, Octane

Leigh Steinberg, Chairman of Leigh Steinberg Sports and Entertainment Holdings

PANEL

Innovations and Impact: The Neurovascular Frontier in Orange County

Orange County, California, is and has been at the forefront of innovations in both neurovascular and neuroscience fields, creating a vibrant ecosystem for clinical breakthroughs and technological advancements. This panel will explore the synergies between neurovascular and neuroscience research, with a special focus on how these disciplines are converging to address complex neurological conditions. Experts will discuss collaborative efforts driving innovation, from cutting-edge therapies to pioneering medical devices. This panel will offer insights into what to expect at the Neuro Tech Forum in April 2024. Attendees will gain a preview of key trends, upcoming innovations, and how the forum will serve as a platform for advancing both fields globally through new research, partnerships, and technology solutions.

Moderator: Khurram Mir, Director, Innovation, UCI Health

Mark Dickinson, World Wide President Neurovascular, Johnson & Johnson Medtech

Jag Dosanjh, President Neurosciences & Eye, SVP AbbVie

Azadeh Nasibi, Vice President of Business Development, Strategy and Region Led Markets (RLM), Medtronic’s Neurovascular Operating Unit

EXPERIENCE

Closing Comments

EXPERIENCE

OCTANEFEST

The Catalina Ballroom

We are thrilled to be able to gather attendees together to solidify the connections made throughout the day at this invaluable networking event!  Strategics, entrepreneurs, investors and industry experts will all be in attendance.  The event will feature various beers, light hors d’oeuvres, and libations. 

EXPERIENCE

Registration & Networking Exhibitor Breakfast

EXPERIENCE

Welcome

PANEL

A View from Strategics: MedTech Innovation through Industry Leaders

This panel gathers top executives from leading MedTech companies to share their strategic perspectives on the future of healthcare technology. Discussion topics include innovation priorities, mergers and acquisitions, partnerships, and key areas like AI, robotics, and digital health. The panelists will provide insights into how major corporations are driving growth, balancing in-house R&D with external investments, and shaping the future of MedTech through strategic decisions.

Moderator: Jim Mazzo, Executive Chairman, Neurotech; Co-Founder, Octane

Doug Faunce, PhD, Executive Director, Head of Search and Evaluation for Eye Care, AbbVie Ventures

Christine Heyninck-Jantz, Vice President R&D, Transcatheter Heart Valves, Edwards Lifesciences

Biren Mehta, Vice President, Venture Investments, Johnson & Johnson

KEYNOTE

Failures as an Innovator: Lessons Learned in the Journey

Anthony Chang, MD, MBA, MPH, Chief Intelligence and Innovations Officer, Children’s Hospital of Orange County; Founder, AIMed

EXPERIENCE 

AWARD – Medical Innovation Prize

Anthony Chang, MD, MBA, MPH, Chief Intelligence and Innovations Officer, Children’s Hospital of Orange County; Founder, AIMed

CAPITAL & GROWTH

Octane Portfolio Companies  (5 companies)

Octane portfolio companies will pitch their products to our investor ecosystem with key strategics and physicians.

Emcee:

Presenting Companies:
Moonrise Medical
Finally Quiet
Pulse Medica
Elle Medical
Oraq.ai

Judges:

EXPERIENCE

Lunch with Experts

PANEL

Going Global – Accessing Different Geographic Regions

Exploring the value of global expansion of medical startups and the critical role of diverse reimbursement strategies, clinical trial designs, and regulatory approvals. Hear from industry pioneers as they share insights into navigating the complexities of entering new markets and adapting to regional healthcare systems. Learn how tailored reimbursement
approaches can drive success, foster innovation, and enhance patient access to cutting-edge medical solutions across different countries. Engage with experts to understand the challenges and opportunities in scaling medical startups on a global stage.

Moderator: Adam Lohr, CPA, Partner and Western Region Life Sciences Leader, RSM

Timothy Pratt, Executive Director and Global Head Medical Device & Diagnostics Research, ICON

Mohammad E. Kondri, MPH, MBA, Sr. International Business Development Officer, Trade Commissioner, Life Sciences, Consulate General of Canada

Yosuke Matsubara, PhD, PMP, Senior Manager of Business Development & License Department, Teijin Pharma Ltd.

Chi Tran, Officer-in-Charge, Hong Kong Trade Development Council

CAPITAL & GROWTH

Octane Portfolio Companies (5 companies)

Octane portfolio companies will pitch their products to our investor ecosystem with key strategics and physicians.

Emcee: Natalie Harney, Certified Business Performance Advisor, Insperity

Companies
Corstasis
Memorycare AI
Zuno Medical
Aruna Revolution 
Prosetta Biosciences

Judges:

People’s Choice and Judge’s Choice Winners Announced

PANEL

Ethical Considerations and Regulatory Frameworks in AI-Driven Healthcare

Engage in a thought-provoking discussion on the ethical implications of AI adoption in healthcare, including issues of bias, privacy, and data security. Examine existing regulatory frameworks and policy considerations for AI-driven healthcare solutions, and explore strategies for ensuring responsible and equitable deployment.

Moderator: Shawn Collins, Partner, Stradling

Sam King, FHFMA, FHIMSS, EHRC, Past President, HFMA and HIMSS SoCal; Faculty, USC Price School of Public Policy.

Sharief Taraman, MD, DABPN, DABPM, FAAP, CEO, Cognoa

Yu Zhao, Founder & President, Bridging Consulting

EXPERIENCE

Closing Comments: Charting the Future of Healthcare Innovation with AI

EXPERIENCE

Community Impact Celebration & Reception